John Craig Thompson - 01 Jul 2025 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
01 Jul 2025
Transactions value $
$0
Form type
3
Filing time
02 Jul 2025, 08:18:47
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
THOMPSON JOHN CRAIG Director C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 02 Jul 2025 0001509643

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.